1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Peru Pharmaceuticals and Healthcare Report Q2 2016

Peru Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 85 pages

Includes 3 FREE quarterly updates

BMI View: In spite of its small market size and developing health care system, its promising economicoutlook and its government's commitment to increased investment in the healthcare sector will be factorscontributing to the improvement of Peru's pharmaceutical business environment. We believe that, over thenext decade, drugmakers and medical device firms will enjoy revenue growth in the country, in the light ofefforts to achieve greater health coverage and improved health indicators.

Headline Expenditure Projections

- Pharmaceuticals: PEN4.98bn (USD1.57bn) in 2015 to PEN5.32bn (USD1.50bn) in 2016; +6.7% inlocal currency terms and -4.0% in US dollar terms.

- Healthcare: PEN33.9bn (USD10.6bn) in 2015 to PEN36.8bn (USD10.4bn) in 2016; +8.5% in localcurrency terms and -2.4% in US dollar terms.

Table Of Contents

Peru Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Peru 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Peru 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Peru 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Peru 2014-2020) 28
Industry Risk Reward Indices 29
Americas Risk/Reward Index 29
Peru Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 38
Intellectual Property Issues 40
Pricing Regime 42
Table: Peruvian Watchdog of Pharmaceutical Products (Observatorio Peruano de Productos Farmaceuticos, OPPF) 43
Reimbursement Regime 43
Table: Price Components Of Two Imported Medicines In Both Private And Public Sectors 44
Market Overview 45
Healthcare Sector 46
Table: MINSA's Decentralised Institutions and Institutes, 2015 46
Table: Healthcare Resources (Peru 2010-2015) 48
Table: Healthcare Personnel (Peru 2010-2015) 49
Table: Healthcare Activity (Peru 2010-2015) 49
Research and Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 58
Table: Members of ADIFAN, 2014 59
Generic Drugmakers 59
Pharmaceutical Distribution 60
Pharmaceutical Retail 61
Company Profile 64
Hersil 64
Novartis 67
Sanofi 69
Unimed 72
Demographic Forecast 74
Demographic Outlook 74
Table: Population Headline Indicators (Peru 1990-2025) 75
Table: Key Population Ratios (Peru 1990-2025) 75
Table: Urban/Rural Population and Life Expectancy (Peru 1990-2025) 76
Table: Population By Age Group (Peru 1990-2025) 76
Table: Population By Age Group % (Peru 1990-2025) 77
Glossary 79
Methodology 81
Pharmaceutical Expenditure Forecast Model 81
Healthcare Expenditure Forecast Model 81
Notes On Methodology 82
Risk/Reward Index Methodology 83
Index Overview 84
Table: Pharmaceutical Risk/Reward Index Indicators 84
Indicator Weightings 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.